Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum
April 26 2021 - 9:05AM
Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the
“Company”), a clinical-stage biopharmaceutical company primarily
focused on the development of novel drugs that are designed to
deter abuse in the treatment of CNS disorders, announced today that
David Baker, President & Chief Executive Officer of Vallon will
participate at the virtual 4th Annual Neuroscience Innovation Forum
being held April 28-30, 2021.
A video webcast of the Company’s presentation is
now available on-demand in the Showcase section of the conference
portal and will be accessible on the conference platform until May
26, 2021. Following the event, the presentation will be made
available on the Company’s website.
Additionally, Mr. Baker will be a panelist on
the virtual Advances in Neuropsychiatry Panel, being held on April
29, 2021 at 10:30 AM ET. The live webcast of the panel will be
accessible to those registered to attend the conference.
Management will also be available to participate
in virtual one-on-one meetings with qualified members of the
investor community who are registered to attend the conference. To
schedule a meeting, please contact the conference one-on-one desk
or reach out through the online platform.
For more information about the event, please
visit the conference website.
About Vallon Pharmaceuticals
Inc.
Vallon Pharmaceuticals Inc. is a clinical-stage
biopharmaceutical company, headquartered in Philadelphia, PA. The
Company is focused on the development of new medications to help
patients with central nervous system (CNS) disorders. The Company’s
lead investigational product candidate, ADAIR, is a novel abuse
deterrent formulation of amphetamine immediate release being
developed for the treatment of ADHD and narcolepsy.
For more information about the company, please
visit www.vallon-pharma.com.
Investor Contact:JTC Team,
LLCJenene Thomas(833) 475-8247vallon@jtcir.com
Vallon Pharmaceuticals (NASDAQ:VLON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vallon Pharmaceuticals (NASDAQ:VLON)
Historical Stock Chart
From Apr 2023 to Apr 2024